This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.

Ozempic vs Wegovy: Same Molecule, Different Program — What Actually Differs

Same molecule (semaglutide), same manufacturer (Novo Nordisk), different brand names with different indications. Here's what actually distinguishes Ozempic from Wegovy.

The Real Differences

FeatureOzempicWegovy
Approved indicationType 2 diabetesChronic weight management
FDA-approved dose rangeUp to 2 mg weeklyUp to 2.4 mg weekly
Insurance coverage patternsBroadly covered for T2DMore restricted for weight
Cash-pay pricingVaries (retail cash)NovoCare tiers
Off-label weight-loss useHistorically commonOn-label

Sesame Care

Brand-name pathways

Marketplace for brand-name FDA-approved GLP-1 only.

  • Brand-name only
  • Direct consult marketplace
  • Cash-pay clarity
Check Latest Pricing

Found Health

$100 off promo

Brand-name GLP-1 access with coaching layer.

  • Brand-name focus
  • Coaching + accountability
  • Insurance-coordinated
Check Latest Pricing

Why the Two Brands Exist

The two brands reflect regulatory structure. FDA approvals are for specific indications; a drug approved for type 2 diabetes has to go through a separate approval process to be marketed for weight management, and typically at different doses. Novo pursued Ozempic (T2D) first and Wegovy (weight management) as a separate development track with its own trials, doses, and label.

The molecule itself — semaglutide — is identical in both products. What differs is the branded packaging, the dosing device (pens), the FDA-approved indication, and how insurance covers it.

The Off-Label Prescribing Pattern

Prescribers historically wrote Ozempic off-label for weight loss when Wegovy wasn't available or covered. This was legal but insurance-dependent — some plans covered Ozempic broadly, others required diabetes diagnosis. Post-Wegovy approval and post-shortage, off-label Ozempic prescribing for weight loss has diminished as Wegovy access has improved and payers have tightened Ozempic prior authorization for non-diabetes use.

Oak Weight Loss

GLP-1 program

Telehealth program with compounded GLP-1 access.

  • Compounded GLP-1
  • Standard intake
  • Membership pricing
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

For Patients Currently on Ozempic for Weight Loss

If you're on Ozempic off-label for weight loss, discuss with your prescriber whether transitioning to Wegovy makes sense. Wegovy's higher approved dose (2.4 mg vs 2 mg) may provide additional weight loss. Coverage decisions may work better with the on-label prescription. Practical continuity should be smooth given the same underlying molecule.

Embody

Injectable semaglutide, $400 CPA tier

Injectable semaglutide only — lead compounded option.

  • Injectable semaglutide focus
  • Standard titration
  • Direct pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

The Compounded Consideration

Compounded semaglutide isn't Ozempic and isn't Wegovy — it's compounded semaglutide, prepared for individual patients under 503A rules. It's the same molecule but not the same product. For patients who want the molecule at lower cost and don't need the FDA-approved product, compounded pathways offer that option (with the trade-offs discussed in other articles on this site).

MadeMed

Compounded GLP-1 options

Independent compounder — sema, tirz, and oral formats.

  • Compounded sema/tirz
  • Oral tirz $167-229
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Telos Rx

Compounded tirzepatide

Compounded tirzepatide via direct pharmacy.

  • Compounded tirzepatide
  • Direct-link intake
  • Verify pricing
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Where to Start

Embody

Injectable semaglutide, $400 CPA tier

Injectable semaglutide only — lead compounded option.

  • Injectable semaglutide focus
  • Standard titration
  • Direct pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

MadeMed

Compounded GLP-1 options

Independent compounder — sema, tirz, and oral formats.

  • Compounded sema/tirz
  • Oral tirz $167-229
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing